Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Announces Second Quarter 2018 Results
GAAP revenues of $189 million, up 4.2% year-over-year GAAP net income per diluted share of $0.16, up $0.11 year-over-year Non-GAAP revenues of $189 million, up 4.0% year-over-year Non-GAAP net income per diluted share of $0.46, up $0.13 year-over-year MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release Second Quarter 2018 Earnings Results on July 26, 2018
MOUNTAIN VIEW, Calif. , July 19, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second...
View HTML
Toggle Summary Omnicell Announces First Quarter 2018 Results
GAAP revenue of $183 million, up 23% year-over-year GAAP net income per diluted share of $0.07, up $0.35 year-over-year Non-GAAP revenue of $183 million, up 23% year-over-year Non-GAAP net income per diluted share of $0.29, up $0.22 year-over-year MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release First Quarter 2018 Earnings Results on April 26, 2018
MOUNTAIN VIEW, Calif. , April 19, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, April 26, 2018 , to discuss the Company's...
View HTML
Toggle Summary Omnicell To Present At Needham & Company's 17th Annual Healthcare Conference
MOUNTAIN VIEW, Calif. , March 22, 2018 /PRNewswire/ --  Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Needham & Company's 17 th Annual Healthcare Conference at the...
View HTML
Toggle Summary Omnicell Reports Results for Fiscal Year and Fourth Quarter 2017
Record yearly GAAP revenue of $716.2 million<br>Record yearly Non-GAAP revenue of $717.4 million<br>2017 GAAP net income per diluted share of $0.53<br>2017 Non-GAAP net income per diluted share of $1.33<br>Record ending product backlog of $345 million...
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2017 Earnings Results on February 1, 2018
MOUNTAIN VIEW, Calif. , Jan. 25, 2018 /PRNewswire/ --   Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 1, 2018 , to discuss the Company's...
View HTML
Toggle Summary Omnicell To Present At The 36th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. , Dec. 14, 2017 /PRNewswire/ --  Omnicell, Inc.  (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 36 th  Annual J.P....
View HTML
Toggle Summary Omnicell To Present At The 29th Annual Piper Jaffray Healthcare Conference
MOUNTAIN VIEW, Calif. , Nov. 16, 2017 /PRNewswire/ --  Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 29 th Annual Piper Jaffray Healthcare Conference at the...
View HTML
Toggle Summary Omnicell Achieves Record Revenue in the Third Quarter 2017
GAAP revenue of $186.8 million and GAAP net income per diluted share of $0.16<br>Non-GAAP revenue of $187.1 million and non-GAAP net income per diluted share of $0.42...
View HTML